
Hal Barron, GSK R&D chief
Building up its AI operations, GSK opens a $13M London hub with plans to woo talent now trekking to Silicon Valley
Continuing its efforts to ramp up global AI operations, GlaxoSmithKline has opened a £10 million ($13 million-plus) research base in Kings Cross, London.
The AI hotspot is already home to Google’s DeepMind, and the Francis Crick and Alan Turing research institutes. GSK said it hopes to “tap into the huge London tech talent pool” and attract candidates who might otherwise head to Silicon Valley.
To read Endpoints News become a free subscriber
Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters